DNAH5 and head and neck squamous cell carcinoma: HNSCC patients were grouped into four groups: DNAH5 Mutation/GS-like groups, DNAH5 Mutation/GU-like groups, DNAH5 Wild/GS-like groups, and DNAH5 Wild/GU-like groups (p < 0.001, Figure 7A).